{
    "2020-05-15": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Why Sarepta Has A Leg Up On Pfizer With A Rival Gene Therapy: Analysts",
                "features": {
                    "keywords": [
                        "Sarepta",
                        "Pfizer",
                        "Gene Therapy",
                        "Analysts"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-02",
                "original_text": "Pfizer Posts Positive Data from Duchenne Muscular Dystrophy Candidate, but Still Trails Rival Sarepta Therapeutics",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Duchenne Muscular Dystrophy",
                        "Positive Data",
                        "Sarepta Therapeutics"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-03",
                "original_text": "Trump unveils vaccine effort, says country will be back on its feet with or without one",
                "features": {
                    "keywords": [
                        "Trump",
                        "vaccine",
                        "effort",
                        "country"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "Sarepta Gains After Pfizer DMD Gene Therapy Data Fall Short",
                "features": {
                    "keywords": [
                        "Sarepta",
                        "Pfizer",
                        "DMD",
                        "Gene Therapy",
                        "Data"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Can Pfizer Undercut Sarepta Therapeutics With A Rival Gene Therapy?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Sarepta Therapeutics",
                        "Rival Gene Therapy"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-06",
                "original_text": "Pfizer to launch late stage DMD gene therapy trial despite hospitalizations",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "DMD",
                        "gene therapy",
                        "trial",
                        "hospitalizations"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-07",
                "original_text": "Pfizerâ€™s New Phase 1b Results of Gene Therapy in Ambulatory Boys with Duchenne Muscular Dystrophy (DMD) Support Advancement into Pivotal Phase 3 Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Phase 1b",
                        "Gene Therapy",
                        "DMD",
                        "Phase 3"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}